A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Epoprostenol
Bouteloua gracilis pollen
The risk or severity of adverse effects can be increased when Temocapril is combined with Bouteloua gracilis pollen.
Epoprostenol
Phalaris arundinacea pollen
The risk or severity of adverse effects can be increased when Temocapril is combined with Phalaris arundinacea pollen.
Epoprostenol
Poa compressa pollen
The risk or severity of adverse effects can be increased when Temocapril is combined with Poa compressa pollen.
Epoprostenol
Distichlis spicata pollen
The risk or severity of adverse effects can be increased when Temocapril is combined with Distichlis spicata pollen.
Epoprostenol
Elymus repens pollen
The risk or severity of adverse effects can be increased when Temocapril is combined with Elymus repens pollen.
Epoprostenol
Anthoxanthum odoratum pollen
The risk or severity of adverse effects can be increased when Temocapril is combined with Anthoxanthum odoratum pollen.
Epoprostenol
Agrostis gigantea pollen
The risk or severity of adverse effects can be increased when Temocapril is combined with Agrostis gigantea pollen.
Epoprostenol
Holcus lanatus pollen
The risk or severity of adverse effects can be increased when Temocapril is combined with Holcus lanatus pollen.
Epoprostenol
Phleum pratense pollen
The risk or severity of adverse effects can be increased when Temocapril is combined with Phleum pratense pollen.
Epoprostenol
Lolium perenne pollen
The risk or severity of adverse effects can be increased when Temocapril is combined with Lolium perenne pollen.
Epoprostenol
Dactylis glomerata pollen
The risk or severity of adverse effects can be increased when Temocapril is combined with Dactylis glomerata pollen.
Epoprostenol
Festuca pratensis pollen
The risk or severity of adverse effects can be increased when Temocapril is combined with Festuca pratensis pollen.
Epoprostenol
Poa pratensis pollen
The risk or severity of adverse effects can be increased when Temocapril is combined with Poa pratensis pollen.
Epoprostenol
Sorghum halepense pollen
The risk or severity of adverse effects can be increased when Temocapril is combined with Sorghum halepense pollen.
Epoprostenol
Poa annua pollen
The risk or severity of adverse effects can be increased when Temocapril is combined with Poa annua pollen.
Epoprostenol
Sodium phosphate, monobasic
The risk or severity of nephrotoxicity can be increased when Temocapril is combined with Sodium phosphate, monobasic.
Epoprostenol
Lanthanum carbonate
Lanthanum carbonate can cause a decrease in the absorption of Temocapril resulting in a reduced serum concentration and potentially a decrease in efficacy.
Epoprostenol
Dexniguldipine
The risk or severity of hyperkalemia can be increased when Temocapril is combined with Dexniguldipine.
Epoprostenol
Tetrandrine
The risk or severity of hyperkalemia can be increased when Temocapril is combined with Tetrandrine.
Epoprostenol
Lomerizine
The risk or severity of hyperkalemia can be increased when Temocapril is combined with Lomerizine.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3